Replies to post #25476 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Stock down more than 40% from the average cost basis of his investors. If he didn't sense something was off it shows how detached he was from shareholder interests. Looking ahead, whatever happens I am much more confident with O'Connor gone that we will see fair value in the $20s sooner than later.